Trial Profile
A Phase 1b, Multicentre, Open Label, Study of the Efficacy, Safety and Tolerability of R131 Ointment in Women with Cytological Abnormalities of the Uterine Cervix
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 10 Mar 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- Acronyms Koru
- Sponsors Douglas Pharmaceuticals
- 10 Mar 2021 Status changed from recruiting to discontinued due to slow recruitment.
- 14 Jun 2019 Recruitment completion is expected on 15 Jul 2019.
- 14 Jun 2019 Planned End Date changed from 7 Dec 2019 to 2 Dec 2019.